![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor microenvironment diversity and plasticity in cancer multidrug resistance
Zhi Li, Peihao Yin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188997-188997
Closed Access | Times Cited: 9
Zhi Li, Peihao Yin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188997-188997
Closed Access | Times Cited: 9
Showing 9 citing articles:
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 104
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 104
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 6
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 6
Study of immunosenescence in the occurrence and immunotherapy of gastrointestinal malignancies
Daosong Dong, Yu Xue, Haoran Liu, et al.
Seminars in Cancer Biology (2025)
Closed Access
Daosong Dong, Yu Xue, Haoran Liu, et al.
Seminars in Cancer Biology (2025)
Closed Access
MDSCs in bone metastasis: Mechanisms and therapeutic potential
Zhi Li, Qi Xia, Yujie He, et al.
Cancer Letters (2024) Vol. 592, pp. 216906-216906
Closed Access | Times Cited: 3
Zhi Li, Qi Xia, Yujie He, et al.
Cancer Letters (2024) Vol. 592, pp. 216906-216906
Closed Access | Times Cited: 3
23-Hydroxybetulinic acid attenuates 5-fluorouracil resistance of colorectal cancer by modulating M2 macrophage polarization via STAT6 signaling
Zeping Fan, Yaru Cui, Lanying Chen, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 2
Zeping Fan, Yaru Cui, Lanying Chen, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 2
Recent advances in understanding the immune microenvironment in ovarian cancer
Jinxin Chen, Lu Yang, Yiming Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Jinxin Chen, Lu Yang, Yiming Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Dual impacts of serine/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation
Huan Tong, Z. X. Jiang, Linlin Song, et al.
Cell Metabolism (2024)
Open Access | Times Cited: 1
Huan Tong, Z. X. Jiang, Linlin Song, et al.
Cell Metabolism (2024)
Open Access | Times Cited: 1
The Role of Intracellular and Extracellular Vesicles in the Development of Therapy Resistance in Cancer
Magdalena Wilczak, Magdalena Surman, Małgorzata Przybyło
Current Pharmaceutical Design (2024) Vol. 30, Iss. 35, pp. 2765-2784
Closed Access
Magdalena Wilczak, Magdalena Surman, Małgorzata Przybyło
Current Pharmaceutical Design (2024) Vol. 30, Iss. 35, pp. 2765-2784
Closed Access
DKK1+ tumor cells inhibited the infiltration of CCL19+ fibroblasts and plasma cells contributing to worse immunotherapy response in hepatocellular carcinoma
Guangyu Fan, Ruyun Gao, Tongji Xie, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access
Guangyu Fan, Ruyun Gao, Tongji Xie, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access
Effect of immunotherapy or anti-angiogenesis therapy combined with chemotherapy for advanced triple-negative breast cancer: A real-world retrospective study
Limin Chen, Hanxing Zhou, Huailiang Wu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113516-113516
Open Access
Limin Chen, Hanxing Zhou, Huailiang Wu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113516-113516
Open Access